Ticagrelor versus Clopidogrel in Patients with Acute Coronary SyndromesLars Wallentin, Robert A. Harrington, Richard C. Becker et al.|New England Journal of Medicine|2009Cited by 7.1k
2024 ESC Guidelines for the management of chronic coronary syndromesChristiaan Vrints, John W. McEvoy, Christi Deaton et al.|European Heart Journal|2024Cited by 2.3k
Long-Term Use of Ticagrelor in Patients with Prior Myocardial InfarctionMarc P. Bonaca, Marc S. Sabatine, Deepak L. Bhatt et al.|New England Journal of Medicine|2015Cited by 2k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trialPaul M. Ridker, Hakan Kültürsay, Jean MacFadyen et al.|The Lancet|2017Cited by 1.3k
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trialPaul M. Ridker, Patrick Commerford, Jean MacFadyen et al.|The Lancet|2017Cited by 881